| Literature DB >> 34669038 |
Luigi Canullo1,2, Paolo Pesce3, Donato Antonacci4, Andrea Ravidà5, Matthew Galli5, Shahnawaz Khijmatgar6, Grazia Tommasato6, Anton Sculean7, Massimo Del Fabbro6,8.
Abstract
BACKGROUND: Alveolar ridge preservation (ARP) is a proactive treatment option aiming at attenuating post-extraction hard and soft tissue dimensional changes. A high number of different types of biomaterials have been utilized during ARP to seal the socket, but their effectiveness in terms of soft tissue outcomes has rarely been investigated and compared in the literature.Entities:
Keywords: Alveolar ridge preservation; Collagen membrane; Collagen sponge; Crosslinked; Multidimensional scale; Network meta-analysis; Non-crosslinked; Predictive interval; Ranking; SUCRA; Soft tissue
Mesh:
Substances:
Year: 2021 PMID: 34669038 PMCID: PMC8791918 DOI: 10.1007/s00784-021-04192-0
Source DB: PubMed Journal: Clin Oral Investig ISSN: 1432-6981 Impact factor: 3.606
Fig. 1Flowchart of the study selection process
Characteristics of the study included
| Author Year | Type of RCT | Country | Smoker | Setting | Private sponsor | Antibiotics | Buccal wall | Subject | Healing 1°/2° | Test filler | Control filler | Test sealing | Control sealing | Outcome variables | Measuring technique |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wongpairojpanich 2020 | Parallel | Thailand | Light smoker | University | No | NR | Intact | 30 | 2° | AP | AP | Non-resorbable | Non-resorbable | HWch | CBCT and digital tool (direct scanning, STL files with CBCT |
| Thoma 2020 | Parallel | Switzerland | Heavy smoker | Private Practice | Yes | A = yes B = yes C = no | More than 50% | 36 | 2 | A = XG B = XG | SH | A = NonCross CM B = NO | NO | KM thickness, CCh | Analogic caliper, master cast digital tool (STL files) |
| Sapata 2019 | Parallel | Brazil | Light smoker | University | Yes | NR | Intact | 82 | 2° | XG | XG | NonCross CM | NonCross CM | KM thickness, CCh, HWch | Master cast and digital tool (STL files) |
| Fischer 2018 | Parallel | Germany | Light smoker | University | No | No | Intact and missing | 40 | T1 = 1° T2 = 2° T3 = 1° T4 = 2° | XG | SH | T1 = PG T3 = collagen membrane | T2 = NO T4 = NO | CCh | Master cast and digital tool (STL files) |
| Schnutenhaus 2018 | Parallel | Germany | Light smoker | University | Yes | No | More than 50% | 60 | 2° | SH | SH | Collagen membrane | NO | CCh | Master cast and digital tool (STL files) |
| Tomasi 2018 | Split-mouth | Italy | Heavy smoker | NR | Yes | No | Intact | 27 | 2° | XG | SH | NonCross CM | NonCross CM | CCh, VBH, VPH, HWch | Master cast and digital tool (STL files) |
| Fickl 2017 | Parallel | Germany | Light smoker | University | Yes | No | Intact and missing | 40 | 2° | XG | SH | A = PG B = NO C = Cross CM | NO | VBH | Master cast |
| Zadeh 2016 | Split-mouth | Saudi Arabia | Heavy smoker | University | Yes | NR | A, B = intact C, B = missing | 36 | 2° | C = XG E = XG | A = SH B = SH D = SH | Group B: non-resorbable device Group C: non-resorbable device Group E: non-resorbable device | Group A:NO Group D:NO | CCh | Master cast and digital tool (STL files) |
| Flugge 2015 | Split-mouth | Germany | Non-smoker | University | Yes | NR | Intact | 38 | 2° | XG | SH | NO | NO | CCh, VBH | Master cast and digital tool (STL files) |
| Engler-Hamm 2011 | Split-mouth | USA | Non-smoker | University | Yes | Yes | Intact | 11 | C group = 1° T group = 2° | AG + XG | AG + XG | PLA/PTMC | PLA/PTMC | KM thickness, VBH | Probe and stent |
| Kesteren 2010 | Parallel | USA | Light smoker | NR | Yes | NR | Intact | 28 | 1° | AG | SH | collagen membrane | NO | VBH | Probe and master cast and photo |
| Vance 2004 | Parallel | USA | NR | NR | Yes | Yes | NR | 24 | 2° | AP + AG | XG | CaS barrier | NonCross CM | KM thickness | Ultrasonic gingival meter, stent and photo |
| Iasella 2003 | Parallel | USA | YES | NR | NR | Yes | NR | 24 | 2° | AG | SH | Cross CM | NO | KM thickness | Ultrasonic gingival meter, stent and photo |
| Ovcharenko 2020 | Parallel | USA | NR | University | Yes | NR | Intact | 20 | 2° | AG + XG | AG + XG | NonCross CM | PLA membrane | KM thickness, CCh, HWch | Probe and stent |
| Clementini 2020 | Parallel | Italy | Light smoker | University | Yes | Yes | Intact | 30 | 2° | XG | SH | NonCross CM | NO | KM thickness, VBH, CCh | Probe and master cast, digital tool (STL files with CBCT) |
| Song 2020 | Parallel | Seoul | Heavy smoker | University | Yes | Yes | Intact | 40 | 2° | XG | SH | NonCross CM | NO | KM thickness, VBH | CBCT and digital tool (direct scanning, STL files with CBCT) |
| Hong 2018 | Parallel | USA | YES | University | Yes | Yes | Intact | 30 | Control = 1° Test = 2° | AG | AG | Cross CM | NonCross CM | KM thickness, VBH | Probe |
| Natto 2017 | Parallel | USA | Light smoker | University | No | Yes | Intact | 28 | 2° | AG | AG | NonCross CM | Collagen sponge | KM thickness, VBH | Probe and stent |
| Festa 2013 | Split-mouth | Italy | Non-smoker | University | No | Yes | Intact | 15 | 2° | XG | SH | cortical porcine laminae | NO | VBH | Probe |
| Barone 2012 | Parallel | Italy | Light smoker | University and Private Practice | Yes | No | Intact | 58 | C group = 1° T group = 2° | XG | SH | NonCross CM | NO | VBH | Probe |
| Schneider 2014 | Parallel | Switzerland | Heavy smoker | University | Yes | Yes | Intact | 40 | 2° | A = AP; B = XG; C = XG | SH | A = PLGA membrane B = NonCross CM C = PG | D = NO | CCh, HWch | Master cast and digital tool (STL files) |
| Thalmair 2013 | Parallel | Germany | Light smoker | Private Practice | Yes | No | Intact | 30 | 2° | XG | SH | A = PG B = PG C = NO | NO | CCh, HWch | Master cast and digital tool (STL files) |
SH spontaneous healing; AU autogenous bone graft; XG xenograft; AG allograft; AP alloplastic; NR not reported; CMC carboxymethyl cellulose; NonCross CM non-crosslinked collagen membrane; Cross CM crosslinked collagen membrane; PG autogenous soft tissue punch graft; ADMG acellular dermal matrix graft; PLA polylactic acid; PLGA poly(glycolide-co-lactide) copolymer; PLA/PTMC polylactic acid/polytrimethylene carbonate; HWch horizontal width change; CCh contour change; VBH vertical buccal height; KMT keratinized mucosa thickness
Qualitative results
| Author Year | Gender (M/F) | Age (mean ± SD or range) | Tooth type/location (Ant/Post) | Arch (max/mand) | Follow-up | Test patients treated | Test patients evaluated | Control patients treated | Control patients evaluated | Complications | Outcome | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test | Control | |||||||||||
| Wongpairojpanich 2020 | 7/23 | 56.07 ± 11 | 60.73 ± 7.98 | 13/17 | 14/16 | 4 mo | 15 | 15 | 15 | 15 | No | B-PPM could potentially be used as an alternative choice for ARP Similar outcomes were observed throughout the evaluation period when compared with commercial d-PTFE membrane |
| Thoma 2020 | 18/18 | A = 53 to 71.5 y B = 55 to 74 y | C = 52 to 71 | A = 16/25 B = 5/8 | 27/9 | 8 w | A = 12 B = 13 | A = 12 B = 13 | C = 11 | C = 11 | No | The thickness of the mucosa in group DBBM-C/CM compared to in group SH, underlines a moderate effect size |
| Sapata 2019 | NR | 43.3 ± 10.3 y | 41.9 ± 11.9 y | 65 A | NR | 4 mo | 41 | 33 | 41 | 33 | No | For main outcome (HWCh) the DBBM group was non-inferior to the DBBM-C group. After 4 months, the use of DBBM was non-inferior to DBBM-C in terms of soft tissue contour changes |
| Fischer 2018 | 16/24 | 55.7 ± 14.85 y | NR | NR | 6 mo | T1 = 10 T2 = 10 T3 = 10 | T1 = 9 T2 = 8 T3 = 10 | 10 | 8 | NR | Three technique result in similar buccal contour change, with smallest changes in T1 | |
| Schnutenhaus 2018 | 29/31 | 24 to 78 y | 19/31 | NR | 6 w | 31 | 31 | 29 | 29 | NR | In the ARP group, there was a statistically significant smaller reduction of the observed soft tissue contour | |
| Tomasi 2018 | 11/16 | 38 to 79 y | 28 P | 16/12 | 6 mo | NR | NR | NR | NR | No | In both the test and control groups, the vertical and horizontal dimension was only modestly reduced between baseline and 6 months | |
| Fickl 2017 | 16/24 | 55.7 ± 14.85 y | NR | NR | 6 mo | NR | NR | NR | NR | No | A and C resulted in significantly less buccolingual dimension loss | |
| Zadeh 2016 | NR | NR | NR | 13/48P | 31/30 | 6 mo | A = 12 t B = 11 t C = 14 t E = 10 t | A = 12 t B = 11 t C = 14 t E = 10 t | D = 14 t | D = 14 t | NR | SocketKAP, with or without ABBM, significantly limited post-extraction ridge contour loss in intact sockets |
| Flugge 2015 | 13/25 | 28 to 78 y | 39/40 | 49/30 | 12 w | 40 teeth | 40 t | 39 t | 39 t | NR | There was a significant difference of the mean dimensional changes: non-augmented sites showing more resorption than augmented sites | |
| Engler-Hamm 2011 | 4/7 | 41.09 ± 14.07 y | 24 P | NR | 6 mo | 11 t | 11 t | 11 t | 11 t | No | MGJ was statistically significantly more coronally displaced in the control group than it was in the test group. Ridge preservation without flap advancement was shown to preserve the buccal keratinized tissue significantly better | |
| Kesteren 2010 | NR | NR | NR | 9 /17 | 21/5 | 6 mo | 14 | 13 | 14 | 11 (13 t) | 1 implant failed | Midbuccal soft tissue margin position shows no significant difference. The same was for interproximal tissue |
| Vance 2004 | 9/15 | 56 ± 14 y | 4/20 | 19/5 | 4 mo | 12 | 12 | 12 | 12 | NR | Soft tissue thickness not significant difference | |
| Iasella 2003 | 10/14 | 51.5 ± 13.6 y | 25/23 | 18/6 | 6 mo | 12 | 12 | 12 | 12 | NR | Sites in the RP group lost a slight amount of overlying soft tissue thickness, while those in the EXT group gained about 0.5 mm | |
| Ovcharenko 2020 | 4/16 | 61 ± 10 y | 48 ± 14 y | 10/10 | 16/4 | 4 mo | 10 | 10 | 10 | 10 | No | Both the PLA and ADMG groups ha significant gain in soft tissue thickness. At 5 mm apical to the crest, PLA group’s gain was significantly greater than ADMG |
| Clementini 2020 | 14/16 | A = 55.5 ± 11.6 B = 52.5 ± 7.5 | C = 50.5 ± 12.2 | 16/14 | 22/8 | 4 mo | 20 | 20 | 10 | 10 | NR | No differences were observed in horizontal changes between the two test treatments and spontaneous healing sites. This lack of difference is related to a significant increase in soft tissue thickness in spontaneous healing sites |
| Song 2020 | 24/11 | 55.3 ± 8.33 y | 50.8 ± 12.6 y | 35 P | NR | 6 mo | 20 | 19 | 20 | 16 | Partial exposure of the bone graft material | The thickness of the mucosa was significantly thinner in ARP group. MGJ moved slightly apically in ARP group and shifted coronally in SH group |
| Hong 2018 | 10/20 | 52.30 ± 17.3 y | 48.50 ± 5.0 | NR | NR | 6 mo | 15 | 14 | 15 | 14 | No | The width of keratinized tissue, the E group gain’s was greater than C group. Same result has found for keratinized thickness |
| Natto 2017 | 17/11 | 25 to 80 y | 30 to 74 y | 11/17 | 23/5 | 4 mo | 14 | 14 | 14 | 14 | NR | Differences between the two groups were not statistically significant for all clinical soft tissue measurement variables |
| Festa 2013 | 12/18 | 28 to 58 y | 28 to 58 y | NR | NR | 6 mo | 15 t | 15 t | 15 t | 15 t | No | Both treatments equally preserved the baseline level of the free gingival margin at the neighboring teeth after the extractions |
| Barone 2012 | NR | 41.8 ± 14.0 y | 39.3 ± 15.5 y | 58 P | NR | 4 mo | 29 | 29 | 29 | 29 | NR | Width of keratinized gingiva was better preserved in the test group compared to the control group |
| Schneider 2014 | NR | NR | NR | 17/23 | NR | 6 mo | A = 10 B = 10 C = 10 | A = 9 B = 9 C = 10 | D = 10 | D = 9 | NR | Application of DBBM-C/CMor DBBM-C/PG reduced the amount of volume resorption compared to ß-TCP or spontaneous healing without reaching statistically significant difference |
| Thalmair 2013 | 18/12 | 24 to 72 y | A = 4/4 B = 4/4 C = 2/5 | 24/6 | 4 mo | A = 8 B = 8 C = 7 | A = 8 B = 8 C = 7 | D = 7 | D = 7 | No | Significant differences in dimensional change between the test groups A and B compared with control group D. A significant influence of the soft tissue socket seal leading to a lower degree in shrinkage. The influence of the filler was estimated to be not significant | |
Quantitative changes. The mean difference data (baseline-last follow-up)
| Code material test | Code material control | Code seal test | Code seal control | KM change (mm) | Buccal change (mm) | Horizontal change (mm) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test | Control | Test | Control | Test | Control | |||||||||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | mean | SD | |||||
| Ovcharenko 2020 | AG + XG | AG + XG | NonCross | Resorbable synthetic | 1.35 | 1.20 | 1.1 | 1.01 | - | - | - | - | A = − 1.65 B = − 1.70 | A = 0.27 B = 0.34 | − 2.86 | 0.31 |
| Clementini 2020 | XG | SH | Non-cross | NO | A = − 0.23 B = − 0.35 | A = 0.69 B = 0.71 | 0.42 | 0.66 | - | - | - | - | − 2.48 | 0.28 | − 2.86 | 0.32 |
| Song 2020 | XG | SH | NonCross | NO | 2.17 | 0.54 | 3.33 | 0.99 | 0.63 | 1.21 | − 0.29 | 0.60 | - | - | - | - |
| Hong 2018 | AG | AG | Cross | NonCross | 0.46 | 0.22 | − 0.15 | 0.23 | 0.43 | 0.42 | − 1.57 | 0.51 | - | - | - | - |
| Natto 2017 | AG | AG | NonCross | ColS | 0.47 | 1.26 | 0.07 | 1.26 | -0.08 | 0.54 | − 0.08 | 1.24 | - | - | - | - |
| Schneider 2014 | A = AP; B = XG; C = XG | SH | A = Resorbable synthetic B = CM C = PG | SH | - | - | - | - | - | - | - | - | A = − 1.69 B = − 1.15 C = − 1.16 | A = 0.74 B = 0.50 C = 0.68 | D = − 1.78 | D = 0.82 |
| Festa 2013 | XG | SH | Cross | SH | 0.1 | 0.2 | 0.1 | 0.2 | ||||||||
| Thalmair 2013 | XG | SH | A = PG B = PG C = NO | SH | - | - | - | - | - | - | - | - | A = 0.79 B = 0.85 C = 1.45 | A = 0.5 B = 0.6 C = 0.7 | D = 2.29 | D = 1.1 |
| Barone 2012 | XG | SH | NonCross | SH | - | - | - | - | 1.14 | 0.8 | 0.73 | 0.8 | - | - | - | - |
| Vance 2004 | AP + AG | XG | Resorbable synthetic | NonCross | 0 | 0.65 | 0.1 | 1.17 | - | - | - | - | - | - | – | - |
| Iasella 2003 | AG | SH | Cross | SH | − 0.35 | 1.11 | 0.45 | 1.14 | - | - | - | - | - | - | - | - |
NR not reported, y years, mo months, w weeks
Fig. 2Overall risk of bias plot
Fig. 3NMA for keratinized mucosa thickness. The size of the circle (Node-blue) is proportional to the number of subjects randomized to that treatment. The thickness of the lines is proportional to the number of studies investigating each comparison (). In NMA, identifying comparisons with large and small contribution is of interest. Therefore, contribution plots are developed to identify the flow of direct, indirect, and mixed evidence in the network (). Direct comparisons 2 vs 3 and 5 vs 3 contributed most to the evidence in the network. Inconsistency plots are used to rule out statistical inconsistency and validate the network (). The predictive interval plot is the interval within which the estimate of a future study is expected to lie. There are three lines, i.e., redline, blue line at the center, black line. The black line is representative of confidence interval (CrI), the red line illustrates the predictive interval (Prl), and the central blue line is the line of no effect. Only in this case, the plot must be read in opposite way as a large value of KMT represents ARP failure (). The multidimensional scale ranking ranks different treatments with their relative incoherence or ranks according to their dissimilarity (). The surface under the cumulative ranking curve (SUCRA) is a numeric presentation of the overall ranking and presents a single number associated with each treatment. SUCRA values range from 0 to 100% (0 to 1). The higher the SUCRA value and the closer to 100%, the higher the likelihood that a therapy is in the top rank (). A Network geometry plot, B contribution plot, C inconsistency plot of entire network, D predictive interval and confidence interval plot, E surface under the cumulative ranking curve (SUCRA), F multidimensional scale ranking (MDS) for keratinized mucosa thickness, Con (treatment n.1) = control; ColS (n.2) = collagen sponge; CM-NonCross (n.3) = collagen membrane non-crosslinked; CM-Cross (n.4) = collagen membrane crosslinked; Resorb Syn (n.5) = resorbable synthetic
Fig. 4NMA for vertical buccal height. A Network geometry plot, the color of the edges corresponds to the average bias risk and the size of the blue dots is proportional to the sample size of that study group. The thickness of the lines demonstrates the number of comparisons made between the two groups of treatment. B Contribution plot. C Inconsistency plot of entire network. D Predictive interval and confidence interval plot: we can consider the values on the left as favoring second intervention and right as favoring first intervention [41]. E Surface under the cumulative ranking curve (SUCRA). F Multidimensional scale ranking (MDS) for keratinized mucosa thickness. Con (treatment n.1) = control; CM-Noncross (n.2) = collagen membrane non-crosslinked, ColS (n.3) = collagen sponge;; CM-Cross (n.4) = collagen membrane crosslinked
Fig. 5NMA for horizontal changes. A Network geometry plot, B contribution plot, C inconsistency plot of entire of entire network, D predictive interval and confidence interval plot, E surface under the cumulative ranking curve (SUCRA), F multidimensional scale ranking (MDS) for keratinized mucosa thickness. Con (treatment n.1) = control; Resorb Syn (n.2) = resorbable synthetic; CM-NonCross (n.3) = collagen membrane non-crosslinked; Auto (n.4) = autogenous graft punch
Quality of direct, indirect, and network evidence for horizontal outcome
| Outcomes | Comparison | Direct evidence | Indirect evidence | Network meta-analysis | |||
|---|---|---|---|---|---|---|---|
| Odds ratio (95% CI) | Quality of evidence | Odds ratio (95% CI) | Quality of evidence | Odds ratio (95% CI) | Quality of evidence | ||
| Horizontal width change (HWch) | Auto vs Con (2 vs 1) | 1.47 (0.22, 2.71) | Moderate | 0.58 (− 0.81, 1.97) | Moderate | 0.88 (− 0.98, 2.75) | Moderate |
| CM-NonCross vs Con (3 vs 1) | 0.37 (0.14, 0.61) | Low | 1.46 (0.65, 2.27) | Moderate | − 1.08 (− 1.93, − 0.24) | Moderate | |
| Resorb:Syn vs Con (5 vs 1) | 0.08 (− 1.21, 1.39) | Low | − 0.67 (− 2.53, 1.17) | Moderate | 0.76 (− 1.50, 3.03) | Moderate | |
| CM-NonCross vs Auto (3 vs 2) | 0.01 (− 1.03, 1.05) | Low | − 0.87 (− 2.42, 0.67) | Moderate | 0.88 (− 0.98, 2.75) | Moderate | |
| Resorb:Syn vs Auto (5 vs 2) | - | - | - | - | - | - | |
| Resorb:Syn vs CM-NonCross (5 vs 3) | − 1.34 (− 2.92, 0.22) | Moderate | − 0.58 (− 2.21, 1.04) | Moderate | -0.76(-3.03,1.50) | Moderate | |
High quality (⊕ ⊕ ⊕)—we are very confident that the true effect lies close to that of the estimate of the effect. Moderate quality (⊕ ⊕ ⊕ O)—we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low quality (⊕ ⊕ OO)—our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. Very low quality (⊕ OOO)—we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
Quality of direct, indirect, and network evidence of keratinized mucosa thickness outcome
| Outcomes | Comparison | Direct evidence | Indirect evidence | Network meta-analysis | |||
|---|---|---|---|---|---|---|---|
| Odds ratio (95% CI) | Quality of evidence | Odds ratio (95% CI) | Quality of evidence | Odds ratio (95% CI) | Quality of evidence | ||
| Keratinized mucosa thickness (KMT) | ColS vs Con (2 vs 1) | - | - | - | - | - | - |
| Con Vs NonCross (1 vs 3) | − 0.67 (− 1.60, 0.26) | Moderate | − 1.40 (− 3.35, 0.53) | Moderate | 0.73 (− 1.41, 2.89) | Moderate | |
| Con vs Cross (1 vs 4) | − 0.8 (− 2.30, 0.70) | Moderate | − 0.06 (− 1.59, 1.47) | Low | − 0.73 (− 2.89, 1.41) | Moderate | |
| Con vs Resorb:Syn (1 vs 5) | - | - | - | - | - | - | |
| NonCross vs ColS (3 vs 2) | - | - | - | - | - | - | |
| ColS vs Cross (2 vs 4) | - | - | - | - | - | - | |
| ColS vs Resorb:Syn (2 vs 5) | - | - | - | - | - | - | |
| Cross vs Non-cross (4 vs 3) | 0.61 (− 0.61, 1.83) | Moderate | − 0.12 (− 1.90, 1.64) | Low | 0.73 (− 1.41, 2.89) | Moderate | |
| NonCross vs Resorb:Syn (3 vs 5) | - | - | - | - | - | - | |
| Resorb:Syn vs Cross (5 vs 4) | - | - | - | - | - | - | |
High quality (⊕ ⊕ ⊕ ⊕)—we are very confident that the true effect lies close to that of the estimate of the effect. Moderate quality (⊕ ⊕ ⊕ O)—we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low quality (⊕ ⊕ OO)—our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. Very low quality (⊕ OOO)—we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
Quality of direct, indirect, and network evidence for buccal outcome
| Outcomes | Comparison | Direct evidence | Indirect evidence | Network evidence | |||
|---|---|---|---|---|---|---|---|
| Odds ratio (95% CI) | Quality of evidence | Odds ratio (95% CI) | Quality of evidence | Odds ratio (95% CI) | Quality of evidence | ||
| Vertical Buccal Height (VBH) | Con vs ColS (1 vs 2) | - | - | - | - | - | - |
| Con vs NonCross (1 vs 3) | 0.61 (− 2.66, − 1.13) | Moderate | − 1.89 (− 2.66, − 1.13) | Moderate | 2.51 (1.58, 3.43) | Moderate | |
| Con vs Cross (1 vs 4) | 0.1 (− 0.39, 0.59) | Moderate | 2.61 (1.83, 3.38) | Moderate | − 2.51 (− 3.43, − 1.58) | Moderate | |
| ColS vs NonCross (2 vs 3) | - | - | - | - | - | - | |
| ColS V Cross | - | - | - | - | - | - | |
| Cross vs NonCross (4 vs 3) | 2.0 (1.41, 2.58) | Moderate | − 0.51 (− 1.22, 0.20) | Low | 2.51 (1.58, 3.43) | Moderate | |
High quality (⊕ ⊕ ⊕ ⊕)—we are very confident that the true effect lies close to that of the estimate of the effect. Moderate quality (⊕ ⊕ ⊕ O)—we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low quality (⊕ ⊕ OO)—our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. Very low quality (⊕ OOO)—we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect